MOBILion Systems, Inc.

MOBILion Systems is enabling advancements in disease diagnosis and treatment by commercializing instruments that improve multi-omics disease, drug, and biomarker discovery. Enhancing the study of the complement to genomics provides a better understanding of disease and drug target mechanisms and paves the way for earlier disease detection, more accurate diagnostics, improved treatment options for individual patients, and reduced healthcare costs. MOBILion’s instruments provide unprecedented speed, sensitivity and resolution, allowing rapid detection of clinically relevant molecules such as proteins, peptides, metabolites, lipids, etc., to better predict, diagnose and treat disease. MOBILion’s instruments process population scale samples in days vs. years, and detect low abundance molecules never before seen with existing instrumentation, providing researchers and clinicians with increased confidence in clinical results.